Thermo Fisher Scientific to Acquire Affymetrix

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Affymetrix Inc. (NASDAQ:AFFX), a leading provider of cellular and genetic analysis products, today announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of Affymetrix for $14.00 per share in cash. The transaction represents a purchase price of approximately $1.3 billion.

Labcritics Alerts / Sign-up to get alerts on discounts, new products, apps, protocols and breakthroughs in tools that help researchers succeed.

Reachout to Researchers with Our Extensive Marketing Network

Modern scientific marketing partner built for life science brands

Visit Labs Reach

Science communicator with more than two decades of experience covering traditional and modern lab technologies such as NGS, LIMS and more recently AIxBio and Decentralized Science. Personally involved in building Unblock Research a platform of concentrated efforts to remove research bottlenecks.